2013
DOI: 10.1016/j.cancergen.2013.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 22 publications
0
11
0
Order By: Relevance
“…One patient died before the start of treatment. The survival time after diagnosis ranged from 16 days to 26 months for the eight patients who died …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…One patient died before the start of treatment. The survival time after diagnosis ranged from 16 days to 26 months for the eight patients who died …”
Section: Resultsmentioning
confidence: 99%
“…4 The t(6;8)(p21;q24) translocation has been reported in other types of malignancy, including follicular lymphoma and acute myeloid leukaemia. 8 Additionally, MYC rearrangements in B-cell lymphomas with a simple karyotype, such as Burkitt lymphomas, are known to respond better to chemotherapy, whereas those with a complex karyotype, such as high-grade B-cell lymphoma with MYC rearrangement and either bcl-2 or bcl-6 translocations, show a very poor clinical outcome, and are refractory to chemotherapy and stem cell transplantation. 21 In our study, when the karyotype was reported, all cases showed a complex karyotype (8/8), indicating that t(6;8)(p21;q24), when accompanied by a complex karyotype, could be related to tumour progression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Whole-exome-sequencing analysis of three cases of blastic plasmacytoid dendritic cell neoplasms confirmed the relationship to the myeloid leukemias [44].…”
Section: Immunophenotypementioning
confidence: 65%
“…60 The common deleted region of 5q is being examined to find candidate genes that may contribute to BPDCN oncogenesis. Genomic losses on 12p and 13q (64%), 6q (50%), 15q (43%), and monosomy 9 (28%) are well described.…”
Section: Can Genetic Markers Assist In the Diagnosis Or Clinical Manamentioning
confidence: 99%